首页> 外文期刊>Japanese journal of clinical oncology. >A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
【24h】

A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.

机译:诱导培美曲塞联合顺铂再行胸膜外肺切除术和术后半胸腔放疗治疗恶性胸膜间皮瘤的可行性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A prospective multi-institutional study has been commenced in Japan to evaluate the feasibility of induction chemotherapy using pemetrexed plus cisplatin, followed by extrapleural pneumonectomy (EPP) and postoperative hemithoracic radiation in patients with resectable malignant pleural mesothelioma. The study was initiated on May 2008 and 40 patients will be recruited over 3 years. Primary endpoints are macroscopic complete resection rate by EPP and treatment-related mortality for trimodality therapy. Secondary endpoints include treatment completion rate, adverse events, response rate by chemotherapy and 2-year overall and relapse-free survival.
机译:在日本已经开始了一项前瞻性的多机构研究,以评估在可切除的恶性胸膜间皮瘤患者中使用培美曲塞加顺铂,然后进行胸膜外肺切除术(EPP)和术后半胸腔放疗进行诱导化疗的可行性。该研究于2008年5月开始,三年内将招募40名患者。主要终点是通过EPP进行的宏观完全切除率和三联疗法的治疗相关死亡率。次要终点包括治疗完成率,不良事件,化疗反应率以及2年总体生存率和无复发生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号